It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
A secretive group linked to a leading European chemical company has joined the campaign to defeat Barack Obama's green agenda, taking the fight beyond the traditional players –the big oil and coal firms – the Guardian has learned.
The previously unknown Coalition for Responsible Regulation Inc (CRR) is at the forefront of a strategy to strip the Obama administration of its powers to regulate greenhouse gas emissions should Congress fail to act on climate change.
The group, which refuses to
has joined more than a dozen states and a host of industry groups in 17 legal challenges to the authority of the Environmental Protection Agency.
Abbott Laboratories' (ABT) first-quarter earnings dropped 30% partly due to the U.S. health-overhaul legislation, while sales rose nearly 15% on solid gains for drugs, medical devices and nutritional products.
The Abbott Park, Ill., company slightly lowered its full-year 2010 earnings forecast to reflect the recent enactment of U.S. health overhaul legislation.
Overall, sales growth accelerated for many Abbott products during the first quarter. Although much of the company's growth has come from its top-selling product, arthritis treatment Humira, Abbott has diversified its business and made several acquisitions recently to reduce its dependence on Humira. In February, it closed the $6.2 billion purchase of Solvay Pharmaceuticals, which Abbott says will expand its business in emerging markets.
In a release this morning, the U.S. company says the acquisition of the Solvay unit “complements Abbott’s presence and expertise in specialty markets such as cardiovascular disease, neuroscience and gastroenterology” and will allow Abbott to get into the global vaccines market.
"The proposed legislation will strip Americans of the right to a trial by jury if harmed by an experimental or licensed drug or vaccine that they are forced by government to take, whenever federal health officials declare a public health emergency.”